Evista Approval For Breast Cancer Risk Reduction Comes With “Black Box” On VTE, Stroke
Lilly’s osteoporosis drug is cleared for use in reducing the risk of invasive breast cancer in two female patient populations.
Lilly’s osteoporosis drug is cleared for use in reducing the risk of invasive breast cancer in two female patient populations.